Venture Capital

The firm's $0.47 Q4 dividend is backed by record income and improving credit quality, offering a compelling case for income and global investors.

A groundbreaking partnership in Italy is creating an AI-powered biobank to transform cancer diagnosis, promising faster, more accurate results for patients.

The 16th Lumiere Awards honor films like 'Sinners' and tech giants like Google, signaling a new era where AI is the co-star in cinematic innovation.

As schools adopt Copilot+ PCs and iOS, Saasyan's new update aims to provide seamless online safety monitoring across a diverse digital classroom.

Belgian biotech Agomab Therapeutics secures $200 million in its Nasdaq debut, fueling its mission to develop therapies for debilitating fibrotic conditions.

As the AI coding market heats up, Cursor's strategic hire of Brian McCarthy signals a major push for enterprise dominance against rivals like GitHub Copilot.

AMD hires Ariel Kelman, a marketing veteran from AWS and Salesforce, to sharpen its brand and accelerate its push into the lucrative AI data center market.

A new company aims to solve why patients stop neurological treatments, focusing on the critical, unsupported time between doctor appointments.

New AI assistants are automating tedious workforce tasks for front-line leaders, promising to free up time and combat rising labor costs and staff shortages.

As the hydrogen economy booms, ANSI is creating the essential safety and technical rulebook needed to unlock its full, clean energy potential.

The pantry brand launches 10 new Regenerative Organic Certified products, expanding its global reach and betting big on a truly sustainable food future.

With new CEO Dr. Hoshang Subawalla, AquaFortus pivots from R&D to global infrastructure, deploying its disruptive brine tech to rewrite water economics.

Amid market volatility, Lavior is boosting US production and launching dual product lines, a strategic move to ensure stability for clinics and consumers alike.

South Korean biotech Galux raises a major Series B round to accelerate its AI platform, which designs novel antibody drugs from scratch with high precision.

Backed by a proven billion-dollar impact model, 14 new startups are using AI, neuroscience, and philanthropy to revolutionize mental healthcare.

A new initiative backed by the Japanese government aims to transform the nation's world-class scientific research into globally competitive biotech companies.

From its unique seat at the World Government Summit, CanSinoBIO unveils its next-gen vaccine pipeline and global strategy to fight humanity's oldest diseases.

After a year-long restructuring, SVCV launches asset manager NextRock to acquire 100 companies and build a cross-industry empire from finance to fashion.

A new alliance between Tend Health and SafeHavenMD offers a confidential lifeline to doctors battling burnout, integrating peer support with clinical care.

With a new flexible, founder-first model, Activation Capital's Frontier BioHealth program aims to bridge the commercialization gap for life sciences startups.